Secondary Logo

Institutional members access full text with Ovid®

Naproxen Sodium for Pain Control With Intrauterine Device Insertion

A Randomized Controlled Trial

Creinin, Mitchell D., MD

doi: 10.1097/AOG.0000000000002078
Departments: Letters
Buy

University of California, Davis, California

Financial Disclosure Dr. Creinin receives speaking honoraria from Allergan and Merck & Co., serves on an Advisory Board for Merck & Co. and is a consultant for Estetra, Health Decisions, and Medicines360. The Department of Obstetrics and Gynecology, University of California, Davis, receives research funding for contraceptive clinical trials from Contramed, Medicines360, Merck & Co., NIH/NICHD and the Society of Family Planning.

© 2017 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.